Literature DB >> 31617417

Current European Trends in Endoscopic Imaging and Transurethral Resection of Bladder Tumors.

Frank Waldbillig1,2, Simon Hein2,3, Britta Grüne1,2, Rodrigo Suarez-Ibarrola2,3, Evangelos Liatsikos4, Georg Salomon5, Alexander Reiterer2,6,7, Christian Gratzke3, Arkadiusz Miernik2,3, Maximilian C Kriegmair1,2, Manuel Ritter2,8.   

Abstract

Purpose: The aim of this survey was to obtain an overview of current European standards in the endoscopic visualization and management of bladder tumors.
Methods: An online survey was launched in July 2018 for a duration of 4 months. It was distributed to all members of the European Association of Urology (EAU) and included 23 questions divided into 3 thematic sections: general information, white light cystoscopy (WLC) and imaging, and transurethral resection of bladder tumor (TURBT) techniques.
Results: Responses of 222 participants were included for analysis. The majority of physicians were between 30 and 40 years of age (48.2%, n = 107) and performed over 50 TURBT per year (52.2%, n = 115). Overall, 52.3% (n = 116) reported WLC findings in written form only, 23.8% (n = 53) added endoscopic footage, and 79.2% (n = 176) considered preliminary WLC/TURBT reports before performing a subsequent bladder intervention. About half of the participants (50.5%, n = 104) used additional tumor visualization methods (aTVMs), but aTVMs were utilized by a greater proportion of physicians from Western countries (58.1%, n = 90) compared with developing countries (20.0%, n = 7). Photodynamic diagnosis was the predominant aTVM technique employed (43.8%, n = 60). Bipolar current was the most common technique for TURBT (46.6%, n = 149). Most urologists in this study occasionally utilized techniques like resections in fractions (80%, n = 161) or en bloc resection (87.2%, n = 182). A repeated TURBT was performed when no muscle was found in the specimen (70.6%, n = 149) and/or if the tumor was stage pT1 (72.0%, n = 152) or high grade (63.0%, n = 133).
Conclusion: Implementation of resection techniques or repeated TURBT within EAU guidelines is promising, but it can be further challenged. For example, WLC/TURBT reporting should be improved since urologists consistently consider previous documentation. Given the moderate application rate of aTVMs, an attempt to increase its utilization would lead to a better assessment of its potential benefit.

Entities:  

Keywords:  bladder cancer; cystoscopy; endoscopic documentation; resection techniques; transurethral resection of bladder tumor; tumor visualization methods

Mesh:

Year:  2019        PMID: 31617417     DOI: 10.1089/end.2019.0651

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

Review 1.  [Enhanced imaging in urological endoscopy].

Authors:  M C Kriegmair; S Hein; D S Schoeb; H Zappe; R Suárez-Ibarrola; F Waldbillig; B Gruene; P-F Pohlmann; F Praus; K Wilhelm; C Gratzke; A Miernik; C Bolenz
Journal:  Urologe A       Date:  2020-12-10       Impact factor: 0.639

Review 2.  Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.

Authors:  S O'Sullivan; M Janssen; Andreas Holzinger; Nathalie Nevejans; O Eminaga; C P Meyer; Arkadiusz Miernik
Journal:  World J Urol       Date:  2022-01-27       Impact factor: 3.661

3.  Efficacy of long-term extended nursing services combined with atezolizumab in patients with bladder cancer after endoscopic bladder resection.

Authors:  Yao Song; Pengjuan Ren; Yang Wu; Baodi Zhang; Junrong Wang; Yue Li
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

4.  Soft Urinary Bladder Phantom for Endoscopic Training.

Authors:  Eunjin Choi; Frank Waldbillig; Moonkwang Jeong; Dandan Li; Rahul Goyal; Patricia Weber; Arkadiusz Miernik; Britta Grüne; Simon Hein; Rodrigo Suarez-Ibarrola; Maximilian Christian Kriegmair; Tian Qiu
Journal:  Ann Biomed Eng       Date:  2021-05-17       Impact factor: 3.934

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.